CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -33.3% | 10,000 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | -25.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | -61.0% | 10,000 | -41.2% | 0.00% | – |
| Q1 2021 | $41,000 | -18.0% | 17,000 | 0.0% | 0.00% | – |
| Q4 2020 | $50,000 | +92.3% | 17,000 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | -52.7% | 17,000 | -23.0% | 0.00% | – |
| Q2 2020 | $55,000 | +22.2% | 22,067 | +0.0% | 0.00% | – |
| Q1 2020 | $45,000 | -42.3% | 22,057 | -12.1% | 0.00% | – |
| Q4 2019 | $78,000 | -25.0% | 25,100 | -19.2% | 0.00% | – |
| Q3 2019 | $104,000 | -12.6% | 31,054 | -16.2% | 0.00% | – |
| Q2 2019 | $119,000 | -11.9% | 37,054 | -21.0% | 0.00% | – |
| Q1 2019 | $135,000 | -42.3% | 46,903 | -19.3% | 0.00% | – |
| Q4 2018 | $234,000 | -17.3% | 58,098 | -4.1% | 0.00% | – |
| Q3 2018 | $283,000 | – | 60,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |